Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Mymensingh Med J ; 33(3): 677-684, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38944706

ABSTRACT

Abnormal uterine bleeding (AUB) is the most common and frequent presenting complaint in Gynaecology in all age group especially in perimenopausal and postmenopausal women. The spectrum of AUB in women of our country includes a wide varieties of organic pathology. The objective of this study was to assess the role of endometrial thickness as a predictor of endometrial malignancy among the women presenting with AUB. This cross-sectional descriptive type of observational study was conducted among 122 women of perimenopausal (40-50 years) and 87 women of postmenopausal (>50 years) age group presenting with AUB in the Obstetrics and Gynaecology department of Mymensingh Medical College Hospital, Bangladesh from February 2020 to August 2021. These patients were subjected to a detailed history and meticulous general, systemic and local examination. The relevant investigations like Transvaginal Sonography (TVS) followed by endometrial biopsy by dilatation and curettage were done in all study participants. Most of the women were in the age group 41-45 years in perimenopause and 51-55 years in postmenopause. Mean±SD was 45.8±4.1 years in perimenopause and 56.3±6.4 years in postmenopause. There was statistical significance in developing endometrial malignancy regarding risk factors of nulliparity, Hypertention (HTN), Diabetes mellitus (DM) and hormone intake between perimenopause and postmenopause. Endometrial thickness was measured in perimenopause and postmenopause. Mean±SD of Endometrial thickness (ET) in perimenopause and postmenopause was 11.3±4.4mm and 7.2±6.3mm with statistical significance (p<0.001). Sensitivity, specificity, Positive predictive value (PPV), Negative predictive value (NPV) and accuracy of TVS were 85.5%, 67.4%, 81.2%, 73.8% and 78.7% in perimenopause and 85.9%, 20%, 89%, 75% & 83.9% in postmenopause. Cut off limit of ET in detection of endometrial malignancy was 18.5mm with sensitivity 74.8% and specificity 63.6% in perimenopause and 12.2mm with sensitivity 81.0% and specificity 65.8% in postmenopausal women. Women with AUB, endometrial malignancy should be suspected when endometrial thickness on TVS >18.5mm and >12.2mm in perimenopause and postmenopausal age group respectively. TVS has high sensitivity in detection of endometrial malignancy both in perimenopausal and postmenopausal women with AUB and TVS is a reliable, noninvasive method.


Subject(s)
Endometrial Neoplasms , Endometrium , Ultrasonography , Uterine Hemorrhage , Humans , Female , Middle Aged , Endometrial Neoplasms/pathology , Endometrial Neoplasms/diagnostic imaging , Endometrial Neoplasms/complications , Cross-Sectional Studies , Endometrium/diagnostic imaging , Endometrium/pathology , Uterine Hemorrhage/etiology , Uterine Hemorrhage/diagnostic imaging , Adult , Risk Factors , Predictive Value of Tests , Bangladesh/epidemiology , Perimenopause , Postmenopause
2.
Int J Pharm ; 586: 119584, 2020 Aug 30.
Article in English | MEDLINE | ID: mdl-32603836

ABSTRACT

Iontophoretic transdermal delivery uses a small electric current to push charged molecules into the skin under an electrode of same polarity and offers an attractive option to facilitate the delivery of macromolecules or hydrophilic molecules and to improve patient compliance. This technique has been used in physical therapy clinics for several decades, though the science was not always there to support claims of clinical effectiveness. Recently, this modality of treatment has undergone more systematic and rigorous investigations to withstand the scrutiny of regulatory authorities. In recent years various drugs have gained FDA approval for iontophoretic patches. This technique is gaining recognition due to better compliance rates, non-invasive drug delivery leading to fewer side effects, and sustained release of the drug. Furthermore, programmed delivery and bolus delivery systems have helped with customizing the drug dosage and frequency of dosage based on the patient's need.


Subject(s)
Iontophoresis , Skin , Administration, Cutaneous , Drug Delivery Systems , Humans , Skin/metabolism , Skin Absorption
4.
Phys Rev Lett ; 88(22): 226803, 2002 Jun 03.
Article in English | MEDLINE | ID: mdl-12059443

ABSTRACT

We show theoretically that in quantum wells subjected to a strong magnetic field the intersubband current peaks at magnetic field values, which reveal the underlying specific intersubband scattering mechanism. We have designed and grown a superlattice structure in which such current oscillations are clearly visible, and in which the transition from the purely single-electron to the mixed single- and two-electron scattering regimes can be observed by tuning the applied voltage bias. The measurements were conducted in ultrahigh magnetic fields (up to 45 T) to obtain the full spectrum of the current oscillations.

10.
Phys Rev B Condens Matter ; 43(11): 9273-9274, 1991 Apr 15.
Article in English | MEDLINE | ID: mdl-9996602
11.
Phys Rev B Condens Matter ; 43(11): 9343-9345, 1991 Apr 15.
Article in English | MEDLINE | ID: mdl-9996623
12.
Phys Rev B Condens Matter ; 42(17): 11400-11403, 1990 Dec 15.
Article in English | MEDLINE | ID: mdl-9995440
13.
Phys Rev B Condens Matter ; 42(12): 7416-7419, 1990 Oct 15.
Article in English | MEDLINE | ID: mdl-9994884
14.
Phys Rev Lett ; 64(1): 44-47, 1990 Jan 01.
Article in English | MEDLINE | ID: mdl-10041269
15.
Phys Rev B Condens Matter ; 40(5): 3433-3436, 1989 Aug 15.
Article in English | MEDLINE | ID: mdl-9992301
16.
Phys Rev B Condens Matter ; 39(4): 2852-2855, 1989 Feb 01.
Article in English | MEDLINE | ID: mdl-9948561
17.
SELECTION OF CITATIONS
SEARCH DETAIL
...